ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. The company is headquartered in Danvers, Massachusetts and currently employs 2,003 full-time employees. The firm develops, manufactures and markets its products, which are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. Its products are used in the cardiac catheterization lab or cath lab, by interventional cardiologists and in the heart surgery suite by cardiac surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty, or heart surgery procedures. The firm's Impella device portfolio includes the Impella 2.5, Impella CP, Impella 5.0, Impella LD, Impella 5.5 and Impella RP devices. Its product pipeline includes Impella ECP, Impella XR Sheath, Impella BTR and precardiac. The Impella ECP device is designed for blood flow of greater than three and a half liters per minute. The Impella BTR device is designed to be a heart pump with integrated motors and sensors.

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories Baxter International Inc Globus Medical Inc HOLOGIC INC IDEXX Laboratories Inc Insulet Corp Masimo Corp Shockwave Medical, Inc. Teleflex Inc Zimmer Biomet Holdings, Inc